Draining a pleural effusion usually begins with a needle-and-catheter procedure called thoracentesis, which can be done at the bedside, often in under 30 minutes. When fluid keeps coming back or is too thick to drain through a needle, the approach escalates to chest tubes, indwelling catheters, or surgery. Each method carries its own balance of benefit and risk, and the choice depends on why the fluid accumulated, how much there is, and whether the problem is likely to recur.
Why Fluid Accumulates in the Pleural Space
A thin layer of fluid normally sits between the two membranes lining your lungs and chest wall. It acts as a lubricant so your lungs can expand smoothly. This fluid is constantly produced and reabsorbed, and the balance is governed by pressure differences between blood vessels and the pleural space itself. When something tips that balance, fluid piles up faster than the body can clear it.1PubMed Central. Clinical overview of the physiology and pathophysiology of pleural fluid movement: a narrative review
Broadly, pleural effusions fall into two categories. Transudates result from pressure imbalances, such as heart failure pushing too much fluid out of blood vessels or liver disease lowering protein levels in the blood. Exudates involve actual damage or inflammation of the pleural membranes, as happens with infections, cancers, or autoimmune conditions. The distinction matters because transudates often improve when you treat the underlying condition, while exudates frequently require direct drainage and investigation of the fluid itself.2PubMed. The pathophysiology of pleural effusions
When Drainage Is Necessary and When It Is Not
Not every pleural effusion needs a needle. Small effusions that appear alongside a known cause, like decompensated heart failure, liver failure, kidney failure, or a pulmonary embolism, can often be managed by treating the underlying problem. Effusions that are too small to sample safely (less than about one centimeter deep on imaging) are also generally left alone.3CHEST. Pleural Fluid Analysis: Maximizing Diagnostic Yield in the Pleural Effusion Evaluation
Drainage becomes necessary when the effusion is large enough to cause significant breathlessness, when its cause is unknown and you need a sample for testing, or when there is concern about infection. In practice, most moderate-to-large effusions without an obvious explanation will be tapped both to relieve symptoms and to send fluid for analysis. That analysis is what tells doctors whether they are dealing with a transudate or an exudate. The most widely used classification system for this has roughly 98% sensitivity for identifying exudates, meaning it rarely misses one.4PubMed Central. Comparison of the Efficacy of Light’s Criteria With Serum-Effusion Albumin Gradient and Pleural Effusion Glucose
Thoracentesis Step by Step
Thoracentesis is the workhorse procedure for pleural effusions. You sit upright, leaning slightly forward over a table to open up the space between your ribs on the affected side. The skin is cleaned and numbed with local anesthetic. A needle, typically attached to a syringe or a small catheter, is advanced over the top of a rib into the fluid collection. (Going over the top rather than under the bottom of a rib avoids the blood vessels and nerves that run along each rib’s lower edge.) Once the needle is in the right spot, fluid is withdrawn either by hand with syringes or through a vacuum bottle.
For a diagnostic tap, only a small amount of fluid is needed, maybe 50 to 100 milliliters. For a therapeutic tap aimed at relieving breathlessness, anywhere from several hundred milliliters to one and a half liters is commonly drained. Most clinicians stop at around 1,000 to 1,500 milliliters in a single session, partly because larger volumes increase the risk of complications and partly because patients sometimes develop chest tightness or coughing as the lung re-expands.
Why Ultrasound Guidance Matters
Ultrasound has become the standard of care for thoracentesis, and the data behind that shift is convincing. A large study of hospitalized patients found that ultrasound guidance was associated with a roughly 19% reduction in the risk of pneumothorax from thoracentesis.5Chest. Ultrasound Guidance Decreases Complications and Improves the Cost of Care Among Patients Undergoing Thoracentesis and Paracentesis A systematic review and meta-analysis pooling over 6,600 thoracenteses found an even more dramatic benefit: ultrasound use was associated with roughly 70% lower odds of pneumothorax compared with procedures done without it.6JAMA Internal Medicine. Pneumothorax Following Thoracentesis: A Systematic Review and Meta-analysis
Ultrasound does two things at once. It confirms exactly where the fluid is and how deep it sits, and it helps the operator avoid nearby structures like the diaphragm and the lung itself. Operator experience also plays a role in safety, with experienced operators showing lower pneumothorax rates than less experienced ones, though that effect is harder to separate from the ultrasound effect in studies that look at both.7PubMed Central. Complications of thoracentesis: incidence, risk factors, and strategies for prevention
Risks of Thoracentesis
Even with ultrasound, thoracentesis is not risk-free. The complications break down into a few main categories.
Pneumothorax
The most commonly tracked complication is pneumothorax, where air enters the pleural space and partially collapses the lung. Across a large meta-analysis, the overall rate was about 6%, and about a third of those cases required a chest tube to fix.6JAMA Internal Medicine. Pneumothorax Following Thoracentesis: A Systematic Review and Meta-analysis Rates were higher after therapeutic (large-volume) taps than diagnostic ones, and symptoms during the procedure, like coughing or sharp chest pain, were strongly associated with pneumothorax. Being underweight also appears to raise the risk, likely because there is less tissue between the skin and the pleural space.8PubMed Central. Incidence and risk factors of iatrogenic pneumothorax after thoracentesis in emergency department settings
One study of 550 patients who had pre-procedural ultrasound-guided thoracentesis found a 12% pneumothorax rate, with those who developed pneumothorax experiencing longer hospital stays and higher in-hospital mortality compared to those who did not. In that study, the volume of fluid drained was independently associated with the risk.9PubMed Central. Incidence and risk factors of pneumothorax following pre-procedural ultrasound-guided thoracentesis The variation in reported pneumothorax rates across studies, from under 1% to 12%, reflects differences in how strictly pneumothorax was looked for (some studies get a chest X-ray on everyone afterward, others only when symptoms arise) and the patient populations studied.
Bleeding
Bleeding is rarer but potentially more dangerous. Hemothorax, where blood fills the pleural space, occurs in roughly one in a thousand to one in ten thousand thoracenteses. The usual culprit is a lacerated intercostal artery, the blood vessel running along the underside of each rib.10PubMed Central. Management of a life-threatening intercostal artery bleeding, difficult to visualize in open surgery: a case report Older patients and those with kidney problems or clotting disorders are at higher risk.11PubMed Central. Intercostal Artery Laceration: Rare Complication of Thoracentesis and Role of Ultrasound in Early Detection The standard advice to insert the needle just above the rib reduces but does not eliminate this risk, because the artery’s position within the intercostal space varies from person to person. Color Doppler ultrasound can sometimes identify aberrant artery locations before needle insertion, though this technique is still underused in practice.12PubMed Central. Intercostal Artery Screening with Color Doppler Thoracic Ultrasound in Pleural Procedures: A Potential Yet Underexplored Imaging Modality for Minimizing Iatrogenic Bleeding Risk in Interventional Pulmonology
Re-expansion Pulmonary Edema
When a lung has been compressed by a large effusion for an extended period, draining the fluid lets it re-expand. Occasionally, that re-expanding lung fills with edema fluid, a condition called re-expansion pulmonary edema. The leading explanation is that the prolonged collapse causes a form of oxygen-deprivation injury to the lung tissue, and when blood flow returns to the re-expanding areas, fluid leaks into the air spaces.13PubMed. Focal reexpansion pulmonary edema after drainage of large pleural effusions: clinical evidence suggesting hypoxic injury to the lung as the cause of edema This is one of the reasons clinicians limit the volume drained in a single session and pay attention to any chest tightness or persistent coughing during the procedure.
Chest Tube Drainage
When thoracentesis is not enough, a chest tube provides continuous drainage. This is common for large or recurrent effusions, infected fluid collections, or situations where the fluid is too thick to pull through a needle. A tube is placed through the chest wall into the pleural space and connected to a drainage system, often involving a one-way valve or an underwater seal that lets fluid and air out but prevents anything from flowing back in. Modern chest drainage units can incorporate digital monitoring systems that track pleural pressure and drainage volume in real time.14PubMed Central. Chest Tubes and Pleural Drainage: History and Current Status in Pleural Disease Management
One of the more meaningful choices in chest tube drainage is between small-bore and large-bore tubes. Small-bore catheters (sometimes called pigtail catheters because of their curled tip) are narrower and can be placed using a wire-guided technique that involves a smaller skin incision. Compared to large-bore tubes, they cause less pain, result in shorter drainage times, and seem to be tolerated better by patients. Studies comparing the two approaches have found similar failure rates and no significant difference in major complications.15PubMed Central. The effectiveness of small-bore intercostal catheters versus large-bore chest tubes in the management of pleural disease with the systematic review of literature Large-bore tubes may carry a slightly higher risk of insertion-related injuries like organ damage or vascular injury, while small-bore tubes are a bit more prone to malposition or blockage. For straightforward pleural effusions, the trend has moved firmly toward small-bore catheters.16PubMed Central. Ultrasound-guided small-bore chest drain placement: a retrospective analysis of feasibility, safety and clinical implications in internal medicine ward
Indwelling Pleural Catheters for Recurring Effusions
Some effusions, particularly those caused by cancer, come back repeatedly. Draining a liter of fluid every few weeks gets exhausting, both for the patient and for the healthcare system. Indwelling pleural catheters (IPCs) offer an alternative: a tunneled catheter is placed semi-permanently into the pleural space, with an external port that can be accessed at home. The patient or a caregiver connects a vacuum bottle and drains fluid whenever breathlessness worsens, typically every one to three days.
The quality-of-life gains from IPCs are substantial. In a ten-year experience tracking 90 patients with malignant effusions, all considered the catheter effective and reported reduced breathlessness and improved well-being. Minor complications occurred in about 11% of patients, and all patients went home the same day the catheter was placed.17European Journal of Surgical Oncology. Home-management of malignant pleural effusion with an indwelling pleural catheter: Ten years experience The ability to manage symptoms at home rather than repeatedly visiting a hospital for thoracentesis is a meaningful shift in how patients experience their illness.18PubMed Central. Indwelling Pleural Catheters for Malignant Pleural Effusion: A Time for Action
An added benefit is that in a meaningful fraction of patients, repeated drainage through an IPC eventually triggers the pleural surfaces to stick together on their own, a spontaneous pleurodesis that stops the fluid from reaccumulating even after the catheter is removed.
Pleurodesis to Prevent Recurrence
When clinicians want to deliberately prevent fluid from returning, they can perform pleurodesis. The idea is to irritate both pleural surfaces so that they inflame, scar, and fuse together, obliterating the space where fluid would collect. This is done by instilling a chemical agent through a chest tube or during surgery.
Talc is the most widely used agent, valued for its effectiveness, safety profile, and low cost. In one study of talc slurry pleurodesis for malignant effusions, the success rate at 30 days was about 85%, with most patients achieving either complete or partial resolution of fluid reaccumulation. The most common side effects were chest pain and fever, which are expected consequences of the intentional inflammation the procedure creates.19PubMed Central. Effectiveness and Safety of Talc Slurry Pleurodesis in the Treatment of Patients with Malignant Pleural Effusion and Low Karnofsky Performance Status Scores
Pleurodesis works best when the lung can fully re-expand after drainage, allowing the two pleural surfaces to come into contact. If the lung is trapped by tumor or scar tissue and cannot re-expand, pleurodesis will fail because the surfaces never touch. In those cases, an indwelling catheter is usually the better long-term option.
Managing Infected Pleural Fluid
Pleural infections, ranging from a simple parapneumonic effusion to frank empyema (pus in the pleural space), demand a more aggressive approach. Antibiotics alone are not enough once the fluid becomes thick, loculated (divided into pockets by fibrous strands), or overtly purulent. These collections need drainage, and getting it done early makes a real difference.
When a chest tube alone does not clear an infected, loculated effusion, a combination of two drugs instilled directly into the pleural space, tissue plasminogen activator (a clot-busting enzyme) and DNase (an enzyme that breaks down DNA in the thick pus), has become a standard option. A landmark trial found that this combination reduced the amount of infected fluid remaining on chest imaging by significantly more than either drug alone or placebo. It also cut surgical referrals from about 16% in the placebo group to 4% and shortened hospital stays by nearly a week.20New England Journal of Medicine. Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection Subsequent analysis confirmed this approach is cost-effective as well.21European Respiratory Journal. Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection
When medical therapy and drainage fail to control a pleural infection, surgery becomes necessary. Video-assisted thoracoscopic surgery (VATS) allows surgeons to directly break up fibrous adhesions and remove infected tissue through small incisions. It offers less postoperative pain, shorter hospital stays, and faster recovery compared to open thoracotomy. VATS works best in the earlier stages of empyema, before the infection progresses to a heavily scarred, organized phase that may require a full open procedure.22Breathe. Surgical interventions for pleural infection
Drainage in Patients on Blood Thinners
A common dilemma arises when someone who needs a thoracentesis is already taking anticoagulants or antiplatelet drugs. Conventional wisdom has long held that these medications should be stopped before any needle procedure near the lungs, but the evidence on this has become more reassuring than many practitioners realize.
A single-center study of 115 ultrasound-guided thoracenteses performed in patients who had taken a newer oral anticoagulant or clopidogrel within 24 hours before the procedure found zero bleeding complications.23Mayo Clinic Proceedings. The Safety of Ultrasound-Guided Thoracentesis in Patients on Novel Oral Anticoagulants and Clopidogrel: A Single-Center Experience A larger observational study came to a similar conclusion, suggesting that thoracentesis can be safely performed without correcting coagulopathy, low platelet counts, or medication-induced bleeding risk beforehand.24PubMed Central. The safety of thoracentesis in patients with uncorrected bleeding risk
In practice, physician behavior has not fully caught up with this evidence. A survey found that while nearly all physicians would proceed with thoracentesis on a patient taking aspirin, only about half would go ahead in someone on clopidogrel or similar drugs, and those who chose to hold the medication typically waited five to seven days.25PubMed Central. Physician Practice Patterns for Performing Thoracentesis in Patients taking Anticoagulant Medications That gap between evidence and practice means patients sometimes experience unnecessary delays in getting their effusion drained.
Drainage in Mechanically Ventilated Patients
Patients on ventilators develop pleural effusions frequently, and draining them while the patient is on positive-pressure ventilation poses additional challenges. The ventilator pushes air into the lungs, which changes the pressure dynamics in the chest and theoretically raises the risk of complications. Despite these concerns, the procedure appears safe when done carefully. A systematic review found that while ultrasound guidance did not show a statistically significant reduction in pneumothorax risk in this specific population, the overall complication rate was still manageable.26PubMed Central. Utility and safety of draining pleural effusions in mechanically ventilated patients: a systematic review and meta-analysis Techniques like positioning the patient in the lateral decubitus position (lying on their side) have been shown to make the procedure safe even in patients on positive-pressure ventilation.27Chest. Safety of Thoracentesis in Mechanically Ventilated Patients
How Much Symptom Relief to Expect
For many patients, the immediate motivation for drainage is simple: they cannot breathe comfortably. The good news is that therapeutic drainage does improve lung function and oxygen levels. One study found that oxygen saturation rose from about 94% to over 98% after drainage, and lung capacity improved in a dose-dependent fashion. Patients who had more than a liter drained showed the largest gains, with forced vital capacity increasing by close to a liter.28International Journal of Drug Delivery Technology. Correlation Of Pleural Fluid Volume With Improvement In Pulmonary Function And Diaphragmatic Excursion Following Therapeutic Pleurocentesis
There is an important caveat, though. The severity of breathlessness does not always match the size of the effusion, and drainage does not always relieve breathlessness as much as patients or doctors expect.29European Respiratory Journal. Pathophysiology of dyspnoea in pleural effusion This is partly because in many patients, the breathlessness stems not just from the fluid compressing the lung, but from the underlying disease itself. A patient with advanced cancer, for instance, may have diaphragm weakness, lung metastases, anemia, or deconditioning that all contribute to how short of breath they feel. Draining the fluid addresses one piece of the puzzle. If the improvement after drainage is disappointing, it does not mean the procedure failed; it means there are other contributors to the symptom that need attention.
Setting realistic expectations before the procedure matters. Patients whose breathlessness is clearly position-dependent (worse lying flat, better sitting up) tend to get the most dramatic relief, because the positional component is a strong sign that the fluid itself is the main offender. When breathlessness is constant regardless of position, the benefit from drainage is less predictable.